文献速递主动脉疾病

阻断白介素-1β可减缓大鼠模型胸主动脉夹层的进展

Blocking Interleukin-1 Beta Reduces the Evolution of Thoracic Aortic Dissection in a Rodent Model.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2020-09-29

本研究在大鼠模型中探讨白介素-1β(IL-1β)在胸主动脉夹层(TAD)发展中的作用。112只雄性SD大鼠随机分为四组,分别给予β-氨基丙腈(BAPN)诱导TAD,并干预IL-1β或其抗体。结果显示IL-1β加重BAPN诱导的死亡和动脉瘤扩张,而抗IL-1β治疗可部分逆转这些变化,其机制涉及MMP-2/9表达、弹性纤维断裂及生物力学改变。

要点

  • IL-1β加重BAPN诱导的TAD大鼠死亡和动脉瘤扩张。
  • 抗IL-1β抗体可降低死亡率并改善主动脉壁生物力学。
  • IL-1β通过上调MMP-2/9、降解弹性纤维促进TAD形成。

核心结论

  • IL-1β通过改变MMP-2和MMP-9表达、降解主动脉壁基质、导致弹性纤维断裂及改变主动脉壁应力/应变,在TAD形成中起关键作用。
  • 抗IL-1β可减轻上述后期效应,可能成为TAD预后和药物治疗的分子靶点之一。

研究设计与样本

  • 研究使用112只雄性Sprague-Dawley大鼠,等分为四组(对照组、BAPN组、BAPN+IL-1β组、BAPN+IL-1β抗体组),每组28只。
  • TAD模型通过β-氨基丙腈(BAPN)诱导,观察6周后的收缩压、生存率和TAD发展。
  • 采用Western blot检测IL-1β、MMP-2和MMP-9表达,TUNEL法检测细胞凋亡,维多利亚蓝染色检测弹性蛋白浓度,体外测试评估生物力学特性。

主要发现

  • 6周死亡率:对照组0%(0/28),BAPN组53.6%(15/28,与对照组比p < .001),BAPN+IL-1β组75.0%(21/28,与BAPN组比p = .007),BAPN+IL-1β抗体组35.7%(10/28,与BAPN组比p = .023,与BAPN+IL-1β组比p < .001)。
  • BAPN+IL-1β组与BAPN组相比,应力和应变参数降低13.5%-53.5%,弹性蛋白含量降低14%,IL-1β、MMP-2和MMP-9表达分别增高117%、108%和75%。
  • 在BAPN+IL-1β抗体组,上述变化可被抗IL-1β治疗完全(应变、弹性蛋白含量和MMP-2表达)或部分(弹性模量、应力和MMP-9表达)阻断。

临床怎么用

  • 抗IL-1β可能作为未来胸主动脉夹层药物治疗和预后评估的分子靶点。
  • 临床需进一步验证IL-1β及其下游MMP-2/9在TAD患者中的表达和干预价值。

局限性

  • 研究为动物模型(大鼠),结论外推至人类需谨慎。
  • 样本量有限(每组28只),长期疗效和安全性未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracic aortic dissection (TAD) is associated with matrix changes, biochemical changes, and inflammatory markers like interleukin-1 beta (IL-1β). However, the exact mechanism remains unknown. This study aimed to investigate the role of IL-1β, matrix metalloproteinase (MMP)-2, MMP-9, smooth muscle cell apoptosis, and elastic fibre fracture in the development of TAD in a rat model. METHODS: The TAD rat model was induced by β-aminopropionitrile (BAPN). TAD was investigated in 112 male Sprague-Dawley rats, which were equally divided into four groups of 28 rats (Control, BAPN, BAPN + IL-1β, and BAPN + IL-1β antibody). Systolic blood pressure, survival, and the development of TAD were measured after six weeks. Expression of IL-1β, MMP-2, and MMP-9 was measured by Western blot. Apoptosis, aortic elastin concentration, and biomechanical characteristics were measured by the TdT mediated dUTP nick end labelling assay, Victoria blue staining, and in vitro testing. RESULTS: During six weeks, the mortality was 0% (0/28) in the control group, 53.6% (15/28) in the BAPN group (p < .001 compared with the control group), 75.0% (21/28) in the BAPN + IL-1β group (p = .007 compared with the BAPN group), and 35.7% (10/28) in the BAPN + IL-1β antibody group (p = .023 compared with BAPN group and p < .001 compared with the BAPN + IL-1β group). IL-1β treatment deteriorates BAPN induced mortality and aneurysm expansion, which were attenuated by anti-IL-1β treatment. In BAPN + IL-1β group, stress and strain parameters were decreased by 13.5%-53.5% and elastin content was decreased by 14%, and IL-1β, MMP-2, and MMP-9 were expressed higher by 117%, 108%, and 75% when compared with the rats in the BAPN group. Contrarily, in the BAPN + IL-1β antibody group, the above changes could be completely (strain, elastin content, and expression of MMP-2) or partly (elasticity modulus, stress, and expression of MMP-9) blocked by anti-IL-1β treatment. CONCLUSION: IL-1β plays a critical role in TAD formation by altering the expression of MMP-2 and MMP-9, degrading the aortic wall matrix, causing elastic fibre rupture, and changing the stress or strain of the aortic wall. Anti-IL-1β reduces the later effects and could be one of the molecular targets for prognosis and drug treatment of TAD in the future.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Guo LL, Wu MT, Zhang LW, et al. Blocking Interleukin-1 Beta Reduces the Evolution of Thoracic Aortic Dissection in a Rodent Model. Eur J Vasc Endovasc Surg. 2020. PMID: 33004280. doi:10.1016/j.ejvs.2020.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。